IFPMA (International Federation of Pharmaceutical Manufacturers & Associations)
With the support of:
Biotherapeutic medicines are an important and integral component of modern medicinal advancement, and represent the new generation of highly-specific and targeted treatments. This high-level conference will convene international and regional experts and regulators and will serve as a platform to share the experiences and best practices on the development and implementation of biotherapeutic and biosimilar regulations. The sessions will allow discussions and debates on key topics such as regulatory pathways for biotherapeutic medicines and biosimilars; quality aspects of development; comparability and similarity exercises; immunogenicity; pharmacovigilance and safety tracking; and interchangeability. Speakers will include representatives of the World Health Organization; national regulatory authorities; independent experts; academia; and industry.
The meeting is free of charge and is open to any interested party.
Tuesday, 19 November, 2013 - Wednesday, 20 November, 2013
10:00 - 18:00
SA Pacific Time